Enzymotec (Enzymotec) Days Payable : 118.80 (As of Sep. 2017)

View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Days Payable?

Enzymotec's average Accounts Payable for the three months ended in Sep. 2017 was $5.42 Mil. Enzymotec's Cost of Goods Sold for the three months ended in Sep. 2017 was $4.17 Mil. Hence, Enzymotec's Days Payable for the three months ended in Sep. 2017 was 118.80.

The historical rank and industry rank for Enzymotec's Days Payable or its related term are showing as below:

ENZY's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 147.46
* Ranked among companies with meaningful Days Payable only.

Enzymotec's Days Payable declined from Sep. 2016 (219.46) to Sep. 2017 (118.80). It may suggest that Enzymotec accelerated paying its suppliers.

Enzymotec Days Payable Historical Data

The historical data trend for Enzymotec's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Days Payable Chart

Enzymotec Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Days Payable

Get a 7-Day Free Trial

98.85

111.17

179.90

100.27

109.81

Enzymotec Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Days Payable	Get a 7-Day Free Trial															219.46	136.71	125.26	65.86	118.80

Competitive Comparison of Enzymotec's Days Payable

For the Biotechnology subindustry, Enzymotec's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzymotec's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzymotec's Days Payable distribution charts can be found below:

* The bar in red indicates where Enzymotec's Days Payable falls into.

Enzymotec Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Enzymotec's Days Payable for the fiscal year that ended in Dec. 2016 is calculated as

	Days Payable (A: Dec. 2016 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2015 )	+	Accounts Payable (A: Dec. 2016 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2016 )	*	Days in Period
=	( (5.529	+	5.126)	/	2 )	/	17.709	*	365
=	5.3275					/	17.709	*	365
=	109.81

Enzymotec's Days Payable for the quarter that ended in Sep. 2017 is calculated as:

	Days Payable (Q: Sep. 2017 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2017 )	+	Accounts Payable (Q: Sep. 2017 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2017 )	*	Days in Period
=	( (4.66	+	6.188)	/	2 )	/	4.166	*	365 / 4
=	5.424					/	4.166	*	365 / 4
=	118.80

Enzymotec Days Payable Related Terms

Thank you for viewing the detailed overview of Enzymotec's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.enzymotec.com

Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015